Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
-
Anasthesiol Intensivmed Notfallmed Schmerzther · Mar 2016
[Anesthesiological aspects in non-cardiac surgery for patients with congenital heart disease].
There are about 6000 children with congenital heart diseases (CHD) born in Germany each year. This number is constant irrespective of the improving prenatal diagnostics. ⋯ Furthermore, it enables anesthesiologists, who have not so much opportunities to treat patients with CHD, to handle such patients safely and successfully, when further knowledge of underlying heart failure and related pathophysiologic characteristics are known. The purpose of this article is to achieve a respectful and confident treatment for patients who had corrective or palliative operations for CHD.
-
Kurz & bündig - was gibt es Neues rund ums Fachgebiet AINS? Die wichtigsten Meldungen auf einen Blick finden Sie hier. In dieser Ausgabe mit den folgenden Themen: · Früherkennung und Therapie der Sepsis: neue Strategien. · Schmerzmedizin: strukturierte Versorgung statt Arzt-Hopping. · US-Leitlinie zu sparsamerem Einsatz von Anitbiotika. · Apothekerschrank unter der Haut. · Zugunglück in Bayern: Traumanetzwerk bewährt sich. · Medizinischer Monitor mit Augen und Ohren.
-
Anasthesiol Intensivmed Notfallmed Schmerzther · Feb 2016
Review[Prehospitale analgesia in adults].
After securing vital function, treatment of pain is an important aspect in emergency medical care. Irrespective of the underlying disease or injury, pain is an important warning symptom of the body and the most common reason for an emergency alert notification. A patient assesses quality of care and success of prehospital care using the criteria of the extent of pain relief he experiences. ⋯ Above a grade of 4, therapeutic intervention should be initiated with the goal of reducing pain to reach a value of <4, or at least to achieve a reduction by 3 points. The choice of analgesics that can be meaningfully used in pre-hospital emergency medicine is limited. The emergency physician should be aware of available drugs and administration routes.
-
Infections with multi-drug resistant bacteria are increasing worldwide. Glycopeptides, linezolid, daptomycin and 5th generation cephalosporins ("MRSA-cephalsoporins") are used against severe infections with MRSA, combination partners are rifampin and fosfomycin. Treatment options against VRE-infections are limited to linezolid, daptomycin and tigecyclin. ⋯ Colistin shows best in vitro susceptibility against carbapenem-resistant Enterobacteriaceae, followed by fosfomycin and tigecycline. For serious infections with 4MRGN a colistin-based combination treatment with two to three agents is recommended. In such cases a carbapenem as combination partner may be useful.